These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12932589)

  • 1. New insights into the relationship between myocardial perfusion and lipid-lowering.
    Blumenthal RS; Gluckman TJ
    J Am Coll Cardiol; 2003 Aug; 42(4):611-3. PubMed ID: 12932589
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial.
    Schwartz RG; Pearson TA; Kalaria VG; Mackin ML; Williford DJ; Awasthi A; Shah A; Rains A; Guido JJ
    J Am Coll Cardiol; 2003 Aug; 42(4):600-10. PubMed ID: 12932588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What other effects do statins have except their effect on lipids?].
    Tikkanen MJ
    Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins improve myocardial perfusion in metabolic syndrome patients who have perfusion defects on myocardial perfusion imaging and angiographically normal coronary arteries.
    Ulus T; Parspour A; Cavusoglu Y; Entok E; Uslu I; Demirustu C
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):328-34. PubMed ID: 22530349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid lowering therapy in atherosclerosis.
    Aikawa M; Libby P
    Semin Vasc Med; 2004 Nov; 4(4):357-66. PubMed ID: 15861316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and coronary microvascular dysfunction in patients with acute ST segment elevation myocardial infarction.
    Celik T; Demirkol S; Celik M; Yuksel UC; Iyisoy A
    Int J Cardiol; 2012 Mar; 155(3):480-1. PubMed ID: 22245479
    [No Abstract]   [Full Text] [Related]  

  • 7. [NO and atherosclerosis].
    Ohtani K; Egashira K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():544-7. PubMed ID: 15506446
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular health: the emerging appreciation of the endothelium.
    Talley JD
    J Ark Med Soc; 1997 Feb; 93(9):454-5. PubMed ID: 9046759
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels.
    Mostaza JM; Gomez MV; Gallardo F; Salazar ML; Martín-Jadraque R; Plaza-Celemín L; Gonzalez-Maqueda I; Martín-Jadraque L
    J Am Coll Cardiol; 2000 Jan; 35(1):76-82. PubMed ID: 10636263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.
    Eichstädt HW; Eskötter H; Hoffman I; Amthauer HW; Weidinger G
    Am J Cardiol; 1995 Jul; 76(2):122A-125A. PubMed ID: 7604786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional evaluation of lipid-lowering therapy by pravastatin.
    Schoebel FC; Jax TW; Strauer BE; Leschke M
    Circulation; 1998 May; 97(18):1874-5. PubMed ID: 9603548
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of endothelial function in coronary microcirculation by HMG-CoA reductase drugs.
    Di Napoli P; Taccardi AA; Di Gioacchino L; De Caterina R; Barsotti A
    Ital Heart J; 2002 Jun; 3 Suppl 4():20S-23S. PubMed ID: 12116821
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
    Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG CoA reductase inhibition and endothelial function in children with chronic kidney disease (CKD)--a pilot study.
    Mackie FE; Rosenberg AR; Harmer JA; Kainer G; Celermajer DS
    Acta Paediatr; 2010 Mar; 99(3):457-9. PubMed ID: 20050832
    [No Abstract]   [Full Text] [Related]  

  • 15. [Non-lipid effects of statins in atherosclerosis].
    Lévesque H
    Rev Med Interne; 2004 Nov; 25(11):783-5. PubMed ID: 15501346
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone replacement therapy and coronary endothelial function in postmenopausal women.
    Singh A
    Mayo Clin Proc; 2005 Jun; 80(6):825; author reply 825-6. PubMed ID: 15945537
    [No Abstract]   [Full Text] [Related]  

  • 17. Statins and peripheral arterial disease: potential mechanisms and clinical benefits.
    Alnaeb ME; Alobaid N; Seifalian AM; Mikhailidis DP; Hamilton G
    Ann Vasc Surg; 2006 Sep; 20(5):696-705. PubMed ID: 16841271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.
    Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S
    Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New findings on the action of HMG-CoA-reductase inhibitors].
    Laufs U; Böhm M; Liao JK
    Dtsch Med Wochenschr; 1997 Oct; 122(41):1255-9. PubMed ID: 9378055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.